Par Drugs and Chemicals Limited

₹107.79As of Sun 8 Nov 2026, 12:00 UTC
NSE:PARHealthcare
Country India
PE (Fwd) •••
TSR 7Y CAGR 22.84%
Div yield —
ROE 11.51%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.43
PE TTM 10.21
TSR TTM 5.50%
Mkt cap ₹1.326B
ROIC 13.11%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹104
(3.47%)
(62.09%)
Buy 10|6|6|1|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
2.54
2.57
2.53
2.72
17.77%
18.27%
13.82%
10.21%
Revenue₹M
80.97
85.07
82.93
86.72
4.83%
6.19%
3.80%
7.78%
Peers (US$14.28M)
Cap (US$)
PE
13.93M
18.09x
Capital
TTM
5Y
10Y
Leveragex
0.730
(0.097)
(0.093)
EBIT/Intx
3.489
0.124
0.139
Own earn%
286.12
(19.71)
(29.10)
Sh yield%
22.25
44.80
45.70
Owners
Insiders/Inst%
11.04
21.85
Short interest%
1.94
SBC / revenue%
5.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
4–13
$1 testx
0.0
Incr. ROIC%
1